Application of the cost-effectiveness method in improving the pharmacotherapy of multiple myeloma by E. A. Luchinin, M. V. Zhuravleva, T. V. Shelekhova, V. S. Bogova, E. V. Luchinina

Connect to this object online.

Combined Therapy of Arterial Hypertension. The Opinion of a Clinical Pharmacologist by M. V. Zhuravleva, E. V. Luchinina, T. V. Shelekhova, S. Yu. Serebrova, S. A. Belkov, A. I. Dmitriev, G. I. Gorodetskaya

Connect to this object online.

Ademetionine treatment cost analysis of patients with intrahepatic cholestasis and non-alcoholic fatty disease by M. V. Zhuravleva, G. V. Kukushkin, E. V. Luchinina, T. V. Shelekhova, T. R. Kameneva, E. V. Kuznetsova, E. A. Luchinin

Connect to this object online.

Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting by E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov

Connect to this object online.

IMPACT OF ABCB1 AND CES1 GENETIC POLYMORPHISMS ON TROUGH STEADY-STATE DABIGATRAN CONCENTRATIONS IN PATIENTS AFTER ENDOPROSTHESIS OF KNIFE JOIN by D. A. Sychev, A. N. Levanov, T. V. Shelekhova, P. O. Bochkov, N. Р. Denisenko, K. A. Ryzhikova, K. В. Mirzaev, E. A. Grishina, M. A. Gavrilov

Connect to this object online.

New Pharmacogenetic Markers to Predict the Risk of Bleeding During Taking of Direct Oral Anticoagulants by K. B. Mirzaev, D. V. Ivashchenko, I. V. Volodin, E. A. Grishina, K. A. Akmalova, A. A. Kachanova, A. I. Skripka, R. M. Minnigulov, T. E. Morozova, O. A. Baturina, A. N. Levanov, T. V. Shelekhova, A. I. Kalinkin, D. A. Napalkov, A. A. Sokolova, D. A. Andreev, I. N. Sychev, P. O. Bochkov, D. A. Sychev

Connect to this object online.